Search This Blog

Thursday, April 30, 2026

Dexcom posts Q1 2026 revenue $1.192 billion, non-GAAP EPS $0.56, raises full-year margin guidance

 

Dexcom posts Q1 2026 revenue $1.192 billion, non-GAAP EPS $0.56, raises full-year margin guidance

  • Raised full-year 2026 non-GAAP operating margin and adjusted EBITDA margin guidance, while reiterating full-year revenue guidance.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.